Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyethyl starch in hip replacement surgery
NCT01486576Phase 4Completed
- Sponsor
- Regionshospitalet Holstebro
- Start
- Jan 2012
- Primary completion
- Mar 2013
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Volulyte in hypovolemia, sponsored by Regionshospitalet Holstebro. Primary endpoint: Urinary Neutrophil Gelatinase-Associated Lipocalin. Started Jan 2012; status: completed.
02
Drugs
Volulyte
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT01486576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01486576.